Body Mass Index Profile of Adult Patients with Inflammatory Bowel Disease in a Multicenter Study in Northeastern Brazil

References

• Weimers P, Munkholm P. The Natural History of IBD: lessons Learned. Curr Treat Options Gastroenterol. 2018;16(1):101–111. doi:10.1007/s11938-018-0173-3
   PubMedGoogle Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0
   PubMed Web of Science ®Google Scholar
• Quaresma AB, Damiao AOMC, Coy CSR, et al. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: a large population-based study. Lancet Reg Health Am. 2022;9(13):100298. doi:10.1016/j.lana.2022.100298
   Google Scholar
• Jiang K, Chen B, Lou D, et al. Systematic review and meta-analysis: association between obesity/overweight and surgical complications in IBD. Int J Colorectal Dis. 2022;37(7):1485–1496. doi:10.1007/s00384-022-04190-y
   PubMed Web of Science ®Google Scholar
• Jain A, Nguyen NH, Proudfoot JA, et al. Impact of obesity on disease activity and patient-reported outcomes measurement information system (PROMIS) in inflammatory bowel diseases. Am J Gastroenterol. 2019;114(4):630–639. doi:10.14309/ajg.0000000000000197
   PubMed Web of Science ®Google Scholar
• Seminerio JL, Koutroubakis IE, Ramos-Rivers C, et al. Impact of obesity on the management and clinical course of patients with inflammatory bowel disease. impact of obesity on the management and clinical course of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(12):2857–2863. doi:10.1097/MIB.0000000000000560
   PubMed Web of Science ®Google Scholar
• Pringle PL, Stewart KO, Peloquin JM, et al. Body mass index, genetic susceptibility, and risk of complications among individuals with Crohn’s disease. Inflamm Bowel Dis. 2015;21(10):2304–2310. doi:10.1097/MIB.0000000000000498
   PubMed Web of Science ®Google Scholar
• Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14(2):110–121. doi:10.1038/nrgastro.2016.181
   PubMed Web of Science ®Google Scholar
• Khakoo NS, Ioannou S, Khakoo NS, Vedantam S, Pearlman M. Impact of obesity on inflammatory bowel disease. Curr Gastroenterol Rep. 2022;24(1):26–36. doi:10.1007/s11894-022-00840-x
   PubMedGoogle Scholar
• Rajabnia M, Hajimirzaei SM, Hatamnejad MR, et al. Obesity, a challenge in the management of inflammatory bowel diseases. Immunol Res. 2022;70(6):742–751. doi:10.1007/s12026-022-09315-7
   PubMed Web of Science ®Google Scholar
• Michalak A, Kasztelan-Szczerbińska B, Cichoż-Lach H. Impact of obesity on the course of management of inflammatory bowel disease-a review. Nutrients. 2022;14(19):3983. doi:10.3390/nu14193983
   PubMed Web of Science ®Google Scholar
• Swanson SM, Harper J, Zisman TL. Obesity and inflammatory bowel disease: diagnostic and therapeutic implications. Curr Opin Gastroenterol. 2018;34(2):112–119. doi:10.1097/MOG.0000000000000422
   PubMed Web of Science ®Google Scholar
• Lipcsey M, Stein DJ, DeVore ZG, Feuerstein JD. Rising rate of obesity in patients admitted for crohn’s disease increases costs but not mortality. J Clin Gastroenterol. 2021;55(8):716–720. doi:10.1097/MCG.0000000000001421
   PubMed Web of Science ®Google Scholar
• Johnson AM, Harmsen WS, Aniwan S, et al. Prevalence and impact of obesity in a population-based cohort of patients with crohn’s disease. J Clin Gastroenterol. 2022;30:10–1097. doi:10.1097/MCG.0000000000001821
   Google Scholar
• Jarmakiewicz-Czaja S, Sokal A, Filip R. What was first, obesity or inflammatory bowel disease? What does the gut microbiota have to do with it? Nutrients. 2020;12(10):3073. doi:10.3390/nu12103073
   PubMed Web of Science ®Google Scholar
• Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J. Crohn’s disease clinical course and severity in obese patients. Clin Nutr. 2002;21(1):51–57. doi:10.1054/clnu.2001.0503
   PubMed Web of Science ®Google Scholar
• Nascimento AT, Rocha R, Coqueiro FG, Santana GO, Lyra AC. Does obesity complicate inflammatory bowel diseases? J Crohns Colitis. 2012;6(10):1041. doi:10.1016/j.crohns.2012.06.008
   PubMed Web of Science ®Google Scholar
• Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR. The impact of increased body mass index on the clinical course of Crohn’s disease. Clin Gastroenterol Hepatol. 2006;4(4):482–488. doi:10.1016/j.cgh.2005.12.015
   PubMed Web of Science ®Google Scholar
• Singla MB, Eickhoff C, Betteridge J. Extraintestinal manifestations are common in obese patients with Crohn’s disease. Inflamm Bowel Dis. 2017;23(9):1637–1642. doi:10.1097/MIB.0000000000001187
   PubMed Web of Science ®Google Scholar
• Nguyen NH, Ohno-Machado L, Sandborn WJ, Singh S. Obesity is independently associated with higher annual burden and costs of hospitalization in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2019;17(4):709–718.e7. doi:10.1016/j.cgh.2018.07.00
   PubMed Web of Science ®Google Scholar
• Dahiya DS, Kichloo A, Wani F, Singh J, Solanki D, Shaka H. A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations. Intest Res. 2022;20(3):342–349. doi:10.5217/ir.2021.00046
   PubMedGoogle Scholar
• Guardado J, Carchman E, Danicic AE, et al. Obesity does not impact perioperative or postoperative outcomes in patients with inflammatory bowel disease. J Gastrointest Surg. 2016;20(4):725–733. doi:10.1007/s11605-015-3060-4
   PubMed Web of Science ®Google Scholar
• Losurdo G, La Fortezza RF, Iannone A, et al. Prevalence and associated factors of obesity in inflammatory bowel disease: a case-control study. World J Gastroenterol. 2020;26(47):7528–7537. doi:10.3748/wjg.v26.i47.7528
   PubMed Web of Science ®Google Scholar
• Kim SK, Lee HS, Kim BJ, et al. The clinical features of inflammatory bowel disease in patients with obesity. Can J Gastroenterol Hepatol. 2021;2021:9981482. doi:10.1155/2021/9981482
   PubMed Web of Science ®Google Scholar
• Gu P, Luo J, Kim J, et al. Effect of obesity on risk of hospitalization, surgery, and serious infection in biologic-treated patients with inflammatory bowel diseases: a CA-IBD cohort study. Am J Gastroenterol. 2022;117(10):1639–1647. doi:10.14309/ajg.0000000000001855
   PubMed Web of Science ®Google Scholar
• Nic Suibhne T, Raftery TC, McMahon O, Walsh C, O’Morain C, O’Sullivan M. High prevalence of overweight and obesity in adults with Crohn’s disease: associations with disease and lifestyle factors. J Crohns Colitis. 2013;7(7):e241–8. doi:10.1016/j.crohns.2012.09.009
   PubMedGoogle Scholar
• Flores A, Burstein E, Cipher DJ, Feagins LA. Obesity in inflammatory bowel disease: a marker of less severe disease. Dig Dis Sci. 2015;60(8):2436–2445. doi:10.1007/s10620-015-3629-5
   PubMed Web of Science ®Google Scholar
• Hu Q, Ren J, Li G, Wu X, Li J. The impact of obesity on the clinical course of inflammatory bowel disease: a meta-analysis. Med Sci Monit. 2017;23:2599–2606. doi:10.12659/msm.901969
   PubMed Web of Science ®Google Scholar
• Back IR, Marcon SS, Gaino NM, Vulcano DSB, Dorna MS, Sassaki LY. Body composition in patients with crohn’s disease and ulcerative colitis. Arq Gastroenterol. 2017;54(2):109–114. doi:10.1590/S0004-2803.201700000-02
   PubMedGoogle Scholar
• Rocha R, Santana GO, Almeida N, Lyra AC. Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase. Br J Nutr. 2009;101(5):676–679. doi:10.1017/S0007114508032224
   PubMed Web of Science ®Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A. doi:10.1155/2005/269076
   PubMed Web of Science ®Google Scholar
• Queiro R, Rodríguez-Caminero S, Riestra S, de Francisco R, Pérez-Martínez I, Ballina J. Performance of two screening questionnaires for inflammatory arthritis in patients with inflammatory bowel disease. Biomed Res Int. 2018;2018:8618703. doi:10.1155/2018/8618703
   PubMed Web of Science ®Google Scholar
• Steed H, Walsh S, Reynolds N. A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland. Obes Facts. 2009;2(6):370–372. doi:10.1159/000262276
   PubMed Web of Science ®Google Scholar
• Jura M, Kozak LP. Obesity and related consequences to ageing. Age (Dordr). 2016;38(1):23. doi:10.1007/s11357-016-9884-3
   PubMedGoogle Scholar
• Brasil. Instituto Brasileiro de Geografia e Estatística - IBG. Pesquisa nacional de saúde: 2019: Atenção primária à saúde e informações antropométricas [Brazilian Institute of Geography and Statistics - IBG. National health survey: 2019: Primary health care and anthropometric information]. Rio de Janeiro: IBGE; 2020. https://abeso.org.br/wp-content/uploads/2021/07/Pesquisa-Nacional-de-Saude-2019.pdf. Accessed November 08, 2023.
   Google Scholar
• Yerushalmy-Feler A, Galai T, Moran-Lev H, et al. BMI in the lower and upper quartiles at diagnosis and at 1-year follow-up is significantly associated with higher risk of disease exacerbation in pediatric inflammatory bowel disease. Eur J Pediatr. 2021;180(1):21–29. doi:10.1007/s00431-020-03697-2
   PubMed Web of Science ®Google Scholar
• Lee YX, Kwan YH, Lim KK, et al. A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases. Singapore Med J. 2019;60(6):270–280. doi:10.11622/smedj.2019057
   PubMed Web of Science ®Google Scholar
• Chen CH, Chen HA, Liu CH, Liao HT, Chou CT, Chen CH. Association of obesity with inflammation, disease severity and cardiovascular risk factors among patients with ankylosing spondylitis. Int J Rheum Dis. 2020;23(9):1165–1174. doi:10.1111/1756-185X.13912
   PubMed Web of Science ®Google Scholar
• Liew JW, Huang IJ, Louden DN, Singh N, Gensler LS. Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis. RMD Open. 2020;6(1):e001225. doi:10.1136/rmdopen-2020-001225
   PubMed Web of Science ®Google Scholar
• Harper JW, Sinanan MN, Zisman TL. Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(10):2118–2124. doi:10.1097/MIB.0b013e31829cf401
   PubMed Web of Science ®Google Scholar
• Kurnool S, Nguyen NH, Proudfoot J, et al. High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis. Aliment Pharmacol Ther. 2018;47(11):1472–1479. doi:10.1111/apt.14665
   PubMed Web of Science ®Google Scholar
• Gomes TNF, de Azevedo FS, Argollo M, Miszputen SJ, Ambrogini O. Clinical and demographic profile of inflammatory bowel disease patients in a reference center of São Paulo. Brazil Clin Exp Gastroenterol. 2021;14:91–102. doi:10.2147/CEG.S288688
   PubMed Web of Science ®Google Scholar
• Cury DB, Oliveira R, Cury MS. Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - A follow-up study in a private inflammatory bowel disease center (2003–2017) . J Inflamm Res. 2019;12:127–135. doi:10.2147/JIR.S190929
   PubMed Web of Science ®Google Scholar